China SXT Pharmaceuticals Inc (NASDAQ:SXTC) was the recipient of a large decline in short interest during the month of July. As of July 15th, there was short interest totalling 134,000 shares, a decline of 84.3% from the June 30th total of 853,600 shares. Based on an average daily volume of 6,410,000 shares, the days-to-cover ratio is presently 0.0 days. Currently, 1.0% of the company’s stock are short sold.
NASDAQ:SXTC opened at $0.40 on Friday. The company’s 50 day moving average price is $0.50 and its 200-day moving average price is $0.62. China SXT Pharmaceuticals has a 52 week low of $0.34 and a 52 week high of $2.95.
Separately, ValuEngine upgraded shares of China SXT Pharmaceuticals from a “hold” rating to a “buy” rating in a research note on Friday, May 1st.
China SXT Pharmaceuticals Company Profile
China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine tablets in China. It provides oral prescription drugs and supplements under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company offers its products to pharmaceutical distributors, pharmaceutical companies, pharmacies, and hospitals through sales representatives.
Featured Article: What is a put option?
Receive News & Ratings for China SXT Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China SXT Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.